Rare diseases
Investigational molecules
Locations
Back to Spain60 clinical trials in Castilleja De La Cuesta, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes
SpainA study testing maridebart cafraglutide for weight loss in adults with overweight or obesity, with or without type 2 diabetes
SpainA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
SpainStudy of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy
SpainStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
SpainStudy comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus
SpainStudy of pelacarsen and inclisiran in patients with atherosclerotic cardiovascular disease who have high levels of LDL cholesterol and lipoprotein(a)
SpainStudy on the Effects of RO7204239 and Tirzepatide for Weight Loss in Patients with Obesity or Overweight with a Weight-Related Health Issue
SpainStudy on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes
SpainStudy on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity
SpainStudy on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight
SpainStudy on the Effectiveness and Safety of Finerenone for Patients with Chronic Kidney Disease and Type 1 Diabetes
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on type 2 diabetes mellitus and obesity management, evaluating new therapeutic approaches for weight reduction and blood sugar control.
Multiple trials are investigating combination therapies with lifestyle modifications for optimal patient outcomes.
Comprehensive studies addressing atherosclerotic cardiovascular disease and hypercholesterolemia, testing new treatments for reducing major adverse cardiovascular events.
Research focuses on both primary prevention and management of established cardiovascular conditions.
Advanced research in multiple sclerosis treatment, including studies of new therapies and comparative analyses of existing treatments for relapsing-remitting forms.
Trials aim to improve treatment efficacy and patient quality of life.
Investigating treatments for chronic kidney disease, particularly in conjunction with diabetes and hypertension, evaluating novel therapeutic combinations.
Focus on slowing disease progression and improving outcomes in complex renal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
